$IBIO another round of news. Was hoping for a nugget that suggested plans for phase 1 clinical study, or at least a notion that they are working with the fda to get this going. Instead.... “Additional characterization studies of IBIO-202 are ongoing.” Cmon Ibio... Is it ready to advance or not???? I could be wrong, but my opinion is this news is not a significant SP mover.
1
1
1 Like